These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6487472)

  • 21. Influence of inflammatory disease on the clinical pharmacokinetics of atenolol and metoprolol.
    Kirch W; Spahn H; Ohnhaus EE; Köhler H; Heinz U; Mutschler E
    Biopharm Drug Dispos; 1983; 4(1):73-81. PubMed ID: 6839004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of ranitidine on plasma metoprolol and atenolol concentrations.
    Spahn H; Mutschler E; Kirch W; Ohnhaus EE; Janisch HD
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1546-7. PubMed ID: 6133576
    [No Abstract]   [Full Text] [Related]  

  • 23. Food-induced reduction in bioavailability of atenolol.
    Melander A; Stenberg P; Liedholm H; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1979 Nov; 16(5):327-30. PubMed ID: 520399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duration of beta-blockade with metoprolol and atenolol: influence of drug oxidation.
    Freestone S; Lennard MS; Silas JH; Ramsay LE
    Postgrad Med J; 1983; 59 Suppl 3():36-7. PubMed ID: 6647208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.
    Godbillon J; Gerardin A; John VA; Theobald W
    Eur J Clin Pharmacol; 1983; 24(5):655-60. PubMed ID: 6873146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.
    Mutschler E; Spahn H; Kirch W
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):51S-57S. PubMed ID: 6146340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.
    Miners JO; Wing LM; Lillywhite KJ; Smith KJ
    Br J Clin Pharmacol; 1984 Dec; 18(6):853-60. PubMed ID: 6152176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selectivity of acebutolol, atenolol, and metoprolol in healthy volunteers estimated by the extent the drugs occupy beta 2-receptors in the circulating plasma.
    Kaila T; Iisalo E
    J Clin Pharmacol; 1993 Oct; 33(10):959-66. PubMed ID: 8227468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central nervous system kinetics of atenolol and metoprolol in the dog during long term treatment.
    Abrahamsson T; Lignell E; Mikulski A; Olovson SG; Regårdh CG
    Drug Metab Dispos; 1989; 17(1):82-6. PubMed ID: 2566475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diazepam/beta-adrenoceptor antagonist interactions.
    Hawksworth G; Betts T; Crowe A; Knight R; Nyemitei-Addo I; Parry K; Petrie JC; Raffle A; Parsons A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):69S-76S. PubMed ID: 6146341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of cimetidine with metoprolol, propranolol, or atenolol.
    Kirch W; Köhler H; Spahn H; Mutschler E
    Lancet; 1981 Sep; 2(8245):531-2. PubMed ID: 6115283
    [No Abstract]   [Full Text] [Related]  

  • 32. The intra- and inter-subject variability of nifedipine pharmacokinetics in young volunteers.
    Lobo J; Jack DB; Kendall MJ
    Eur J Clin Pharmacol; 1986; 30(1):57-60. PubMed ID: 3709633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. beta-Adrenoreceptor-blocking agents and the blood-brain barrier.
    Cruickshank JM; Neil-Dwyer G; Cameron MM; McAinsh J
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():453s-455s. PubMed ID: 7449299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug interaction between propafenone and metoprolol.
    Wagner F; Kalusche D; Trenk D; Jähnchen E; Roskamm H
    Br J Clin Pharmacol; 1987 Aug; 24(2):213-20. PubMed ID: 3620296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation and adverse effects of metoprolol and propranolol after concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Mutschler E
    Arch Toxicol Suppl; 1983; 6():379-83. PubMed ID: 6578746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accumulation of atenolol and metoprolol in human breast milk.
    Liedholm H; Melander A; Bitzén PO; Helm G; Lönnerholm G; Mattiasson I; Nilsson B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1981; 20(3):229-31. PubMed ID: 7286041
    [No Abstract]   [Full Text] [Related]  

  • 37. Atenolol and metoprolol. A comparison of their excretion into human breast milk.
    Kulas J; Lunell NO; Rosing U; Stéen B; Rane A
    Acta Obstet Gynecol Scand Suppl; 1984; 118():65-9. PubMed ID: 6587730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
    Hallengren B; Nilsson OR; Karlberg BE; Melander A; Tegler L; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1982; 21(5):379-84. PubMed ID: 7075643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of antacid, metoclopramide, and propantheline on the bioavailability of metoprolol and atenolol.
    Regårdh CG; Lundborg P; Persson BA
    Biopharm Drug Dispos; 1981; 2(1):79-87. PubMed ID: 7236872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect on left ventricular performance of nifedipine and metoprolol singly and together in exercise-induced angina pectoris.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Forsyth D; Taylor SH
    Eur Heart J; 1984 Jan; 5(1):67-79. PubMed ID: 6705807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.